Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Suspected vaccination failure; immune system was compromised; I got shingles; had covid; nothing helps the nerve pain; had 3 shingles vaccine; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), immunocompromised (Verbatim: immune system was compromised) (serious criteria GSK medically significant), shingles (Verbatim: I got shingles), covid-19 (Verbatim: had covid), post herpetic neuralgia (Verbatim: nothing helps the nerve pain) and extra dose administered (Verbatim: had 3 shingles vaccine). The outcome of the vaccination failure, immunocompromised, covid-19 and post herpetic neuralgia were not reported and the outcome of the shingles was resolved and the outcome of the extra dose administered was not applicable. It was unknown if the reporter considered the vaccination failure, immunocompromised, shingles, covid-19 and post herpetic neuralgia to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine. The company considered the vaccination failure and immunocompromised to be unrelated to Shingles vaccine, Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles, covid-19 and post herpetic neuralgia to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine. Additional Information: GSK Receipt Date: 29-APR-2025 This case was reported by a patient via interactive digital media. The patient had 3 shingles vaccines. The patient reported to had Covid and then got shingles. The doctor stated that his/her immune system was compromised. The pain was extremely painful and nothing helped the nerve pain. The patient stated hopefully he/she would not get them again. The patient had them in the same place as the woman above. The patient received 3 doses of Shingles vaccine, which led to extra dose administered. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. Immunodeficiency is an unlisted event which is considered unrelated to GSK Shingles vaccine.